setrobuvir (AN598) - Roche
Roche: Late-Stage Pipeline Event (Roche) - Oct 3, 2013 - Anticipated regulatory submission in EU for hep C infection in 2016 or after; Anticipated regulatory submission in US for hep C infection in 2016 or after 
Anticipated EU regulatory • Anticipated FDA event Hepatitis C Virus
http://www.roche.com/investors/ir_agenda/late-stage_pipeline_2013.htm
 
Oct 3, 2013
 
.
 
57be85a1-6ffd-4291-8cc4-a5dfc4bb9379.jpg